Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy

This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.

Authors

Institutions

Publication Details

Journal
South Asian Journal of Cancer
Published
2024-08-29
DOI
https://doi.org/10.1055/s-0044-1789604
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy

Malay Sarkar, Irappa Madabhavi, Vineet Kumar, Raghavendra Sagar et al.
South Asian Journal of Cancer
Lymphoma Diagnosis and Treatment
article

Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy

Malay Sarkar, Irappa Madabhavi, Vineet Kumar, Raghavendra Sagar, Swaroop Revannasiddaiah
article en

Abstract

This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.

South Asian Journal of CancerVol. 14(03)
Indira Gandhi Medical College (IN), HCG Cancer Hospital (IN), KLE Academy of Higher Education and Research (IN)
Good health and well-being
Openalex Percentile: Top 77%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.